Teva Signs Deal With Indirect Buyers In Effexor Antitrust Suit
By George Woolston · October 18, 2024, 7:42 PM EDT
A class of consumers and third-party payers have reached a deal with Teva Pharmaceuticals to resolve antitrust litigation over a purported scheme to delay generic competition for the antidepressant drug Effexor...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login